Public awareness regarding the manufacturer provided information about medicine usage, safety, and adverse drug reactions in Balochistan, Pakistan

被引:2
|
作者
Khan, Gullab [1 ]
Haq, Noman [1 ]
Ahmad, Nafees [1 ]
Nasim, Aqeel [2 ]
Javaid, Asma [3 ]
Saood, Mujhammad [2 ]
Yasmin, Riffat [4 ]
Tahir, Maria [5 ]
Riaz, Sohail [6 ]
Danish, Zeeshan [7 ]
Razzaq, Ghulam [1 ]
Khan, Abdullah [8 ]
Younis, Muhammad [1 ]
Rabbani, Tahmina [1 ]
机构
[1] Univ Balochistan, Fac Pharm & Hlth Sci, Quetta, Pakistan
[2] Prov Drug Testing Lab Balochistan, Quetta, Pakistan
[3] Sardar Begum Dent Hosp, Peshawar, Pakistan
[4] Balochistan Inst Nephrol Urol Quetta, Quetta, Pakistan
[5] Sardar Bahadur Khan Womens Univ, Quetta, Pakistan
[6] Capital Univ Sci & Technol, Islamabad, Pakistan
[7] Univ Punjab, Dept Pharm, Lahore, Pakistan
[8] Civil Hosp Quetta, Quetta, Pakistan
关键词
public awareness; medicine information; safety; Quetta; Pakistan; PATIENT KNOWLEDGE; NATIVE LANGUAGE; HEALTH LITERACY; PERCEPTION;
D O I
10.3389/fphar.2023.1190741
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: This study aimed to analyze the general public's awareness of medicine information, safety, and adverse drug reactions in Quetta, Pakistan.Methods: A cross-sectional descriptive study was conducted using random sampling from April 2020 to April 2021 in Quetta. Samples were collected from respondents who met the inclusion criteria and had visited community pharmacies. The analysis was done using SPSS version 23. Bivariate and multivariate analyses were performed to assess factors associated with good knowledge.Results: Multivariate analysis revealed that purchase on prescription was a determining factor of knowledge regarding knowledge of pharmaceutical products and their provided information, medicines usage and safety, and Medication ADRs. Patients who bought medicines on prescriptions were more likely to have better knowledge. Patients having education were more likely to have better knowledge.Conclusion: Public awareness about medicine information, safety, and the information provided by manufacturers is crucial to ensuring that patients have access to accurate information about their medications and can make informed decisions about their health. Healthcare providers and regulatory bodies must work together to improve access to information and promote safe medication practices.
引用
收藏
页数:11
相关论文
共 4 条
  • [1] Public Awareness about Medicine Information, Safety, and Adverse Drug Reaction (ADR) Reporting in Dammam, Saudi Arabia
    Islam, Md. Ashraful
    Al-Karasneh, Aseel Fuad
    Naqvi, Atta Abbas
    AlShayban, Dhfer Mahdi
    Al-Hayek, Fatimah
    Al-Badrani, Sarah
    Al-Salem, Raghad
    Ghori, Syed Azizullah
    PHARMACY, 2020, 8 (04)
  • [2] Patient expectations and awareness of information regarding adverse reactions in drug labelling in China
    Zhang, Weixia
    Zhang, Jing
    Ma, Renji
    Chen, Hefeng
    Huang, Jingjing
    Xu, Beiming
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (01) : 174 - 180
  • [3] Patients' Use of Information about Medicine Side Effects in Relation to Experiences of Suspected Adverse Drug Reactions: A Cross-Sectional Survey in Medical In-Patients
    Krska, Janet
    Morecroft, Charles W.
    DRUG SAFETY, 2013, 36 (08) : 673 - 680
  • [4] Patients’ Use of Information about Medicine Side Effects in Relation to Experiences of Suspected Adverse Drug Reactions: A Cross-Sectional Survey in Medical In-Patients
    Janet Krska
    Charles W. Morecroft
    Drug Safety, 2013, 36 : 673 - 680